The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the ...

Using advanced computational genomics, Johns Hopkins investigators discovered how prostate cancer develops resistance to treatment.

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

Official recommendations that discourage use of hotly debated screening test could be linked to increase, experts suggest ...

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

It recommends that only men with a confirmed genetic risk of prostate cancer should be screened for the disease.

A groundbreaking trial for a prostate cancer treatment has been launched in the UK, with the hope of reducing the side ...